Metropolitan Life Insurance Company (MetLife)’s Telos TLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-347
Closed -$878 2512
2023
Q1
$878 Sell
347
-3,153
-90% -$12.9K ﹤0.01% 2305
2022
Q4
$17.8K Hold
3,500
﹤0.01% 2075
2022
Q3
$31.1K Hold
3,500
﹤0.01% 1781
2022
Q2
$28.3K Buy
3,500
+788
+29% +$6.79K ﹤0.01% 1856
2022
Q1
$27K Sell
2,712
-8,283
-75% -$92.9K ﹤0.01% 1948
2021
Q4
$170K Hold
10,995
﹤0.01% 2138
2021
Q3
$312K Buy
10,995
+5,666
+106% +$171K ﹤0.01% 1744
2021
Q2
$181K Sell
5,329
-186
-3% -$6.26K ﹤0.01% 2222
2021
Q1
$209K Buy
+5,515
New +$194K ﹤0.01% 1988

Other funds holding TLS

Metropolitan Life Insurance Company (MetLife)'s TLS Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Telos (TLS) in Q2 2023, closing a stake of 347 shares — an estimated $878 sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TLS in Q1 2021 and held it in 9 quarters. The position peaked at $312K in Q3 2021. 106 funds tracked by Wall St. Rank hold TLS as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Telos position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 347 Telos shares in Q2 2023, an estimated $878.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Telos in Q1 2021 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Telos position peaked at $312K in Q3 2021.
  • 106 funds tracked by Wall St. Rank held Telos as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.